The WHO explained Thursday that it's fielded numerous stories of pretend semaglutide — the Lively ingredient in Novo Nordisk's Wegovy and Ozempic — in all geographic regions of the whole world given that 2022. to lessen the potential risk of main cardiovascular functions for example heart attack, stroke, or Loss of life in Grownups with varie